A five-year research study is testing whether treating people for Hepatitis C Virus (HCV) could help to eliminate the virus.
Our researchers are working on the £2.8 million EPIToPe study, funded by the National Institute for Health Research (NIHR), into the prevention of the virus by treatment.
In the first study of its kind, researchers are treating up to 500 people who inject drugs across NHS Tayside. Treatment is being offered in pharmacies, addiction services and prisons.
Our researchers are working with the University of Bristol; University of Dundee; MRC Biostatistics Unit University of Cambridge; Queen Mary University of London; Health Protection Scotland; University of California San Diego; NHS Tayside; Public Health England; Scottish Drugs Forum and the London School of Hygiene & Tropical Medicine.
The study will generate empirical evidence as to whether treating people who inject drugs can reduce the spread of infection. We hypothesise that if HCV treatment is increased sufficiently, eventually the virus could be eliminated.